Utah families celebrate passage of cannabis 'Charlee's Law' – Salt Lake Tribune

(Franciso Kjolseth | The Salt Lake Tribune) Kyle Sintz of South Jordan shares a light moment with his son Isaac, 7, as they wait for Gov. Gary R. Herbert to sign a ceremonial version of HB105 to legalize the use of nonintoxicating cannabis oil by Utahns with untreatable epilepsy. Families gathered in the Gold Room at the Utah Capitol on Tuesday, March 25, 2014, for the signing. HB105, now called ‘Charlee’s Law,” will go into effect on July 1.

Ceremonial signing » Logistics are months from being worked out; University of Utah hopes to study effectiveness of cannabis treatments.

Utah’s hemp supplement bill, better known as “Charlee’s Law,” is a technical piece of legislation, packed with a lot of “legalese,” said sponsor Rep. Gage Froerer at the governor’s ceremonial signing of the law on Tuesday.

But it’s a symbol of compassion for parents who have exhausted all medical remedies for their children, and a promise of hope for a better future, he said.

“And number one it’s about trust,” Froerer said. “The state of Utah is willing to trust the parents of this state in making the decisions they feel are right for their children’s health.”

HB105 gives Utahns with epilepsy trial access to a non-intoxicating, seizure-stopping cannabis oil. But it doesn’t take effect until July 1, 2014, and until then, Utahns can’t legally possess cannabis oil.

And obtaining it after that date will still risk violating federal law — and require jumping through a set of still-vaguely defined hoops.

Currently, patients will need to travel to states where medical marijuana is legal and import cannabis oil themselves. Doing so remains technically a violation of federal law.

That hasn’t stopped states from enacting their own marijuana laws.

Utah Gov. Gary Herbert signed HB105 last week. At Tuesday’s ceremonial signing at the Capitol he applauded families for being the driving force behind a bill that many surmised had no chance of passage and that underwent nine revisions.

Herbert initially had quality control and safety concerns, but said, “I’m satisfied … that we have a bill that is where it needs to be.”

story continues below

story continues below

At the event Tuesday were grassroots organizers of Hope 4 Children With Epilepsy (H4CE) wearing purple in honor of March 26, which is Epilepsy Awareness Day. The parents of the bill’s namesake, Charlee Nelson, one of 50 Utah children on a Colorado waiting list for nonintoxicating cannabis oil, were there. The 6-year-old West Jordan girl died two weekends ago, days after being honored by the Legislature.

Still numb and processing her daughter’s death, Catrina Nelson lamented that Charlee “couldn’t be here with us today.” But she said, “I’m excited to see this work out for so many other families.”

It will be months before the Utah Department of Health fine tunes the process for families to apply for a “hemp supplement” registration card.

The law requires families to first obtain a letter of recommendation from their neurologist, and hospitals are bracing for an influx of calls from families eager to get the ball rolling.

“We are committed to working with these families. We want to be their partner in this journey,” said Edward Clark, pediatrics chairman at University of Utah Health Care and chief medical officer at Intermountain Healthcare’s Primary Children’s Hospital.

But until the health department issues rules, hospitals can’t provide much guidance to patients.

Neurologists are in short supply and high demand in Utah and most of those specializing in untreatable epilepsy work at the U. and at Primary Children’s.

It’s unclear how many adults and children in Utah are candidates for cannabis oil, but most probably already have records on file at these hospitals, said Clark.

He has assigned a task force to create a pipeline to speed requests for recommendation letters. The U. will likely sponsor a hotline where patients can register for information, he said.

“Some patients may require additional testing and some may not,” he said. “I’ve asked our epileptologists to define what they need. …There are people working on this every day trying to get these pieces assembled.”

The U.’s doctors hope to study cannabis oil and chart patients’ progress on it. On a parallel track they have also applied to run an investigational trial of a pharmaceutical-grade cannabis extract for use in children with a severe form of epilepsy called Dravet syndrome.

Next Page >

Copyright 2014 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

This entry passed through the Full-Text RSS service — if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.

Powered by WPeMatico

This entry was posted in Hemp, MMJ, Cannabis Stocks News and tagged . Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback.